新型香豆素酰胺类衍生物的合成及抑菌机制研究
Synthesis and Antibacterial Mechanism Study of Novel Coumarin Amide Derivatives
摘要
本文设计合成了 12个香豆素酰胺类衍生物,评价其对产肠毒素大肠杆菌(ETEC)的抑菌活性并探究其作用机制.采用Perkin反应合成香豆素母核,再与不同的取代胺进行酰胺缩合,制备得到一系列结构新颖的香豆素酰胺类衍生物,产物结构均经核磁共振与质谱确证.采用微量稀释法测定化合物对ETEC的最小抑菌浓度(MIC)与半数抑制浓度(IC50),并对化合物进行构效关系分析.所有目标化合物均对ETEC表现出抑菌活性,其中XA2-4活性最优,MIC为0.5±0.05mg/mL,IC50为0.16±0.02mg/mL.网络药理学筛选得出recA、metG、pyrG等为核心靶点,分子对接显示候选化合物XA2-4与核心靶点蛋白均具有良好的结合亲和力.定量聚合酶链反应验证结果表明,XA2-4可显著下调recA、metG、pyrG基因的表达,其中pyrG基因对药物干预最为敏感.
In this study,twelve coumarinamide derivatives were designed and synthesized to evaluate their antibacterial activity against Enterotoxigenic Escherichia coli(ETEC)and to investigate their mechanism of action.The coumarin core was synthesized via the Perkin reaction,followed by amide condensation with different substituted amines to obtain a series of novel coumarin amide derivatives.Their structures were confirmed by nuclear magnetic resonance and mass spectrometry.The minimum inhibitory concentration(MIC)and half-maximal inhibitory concentration(IC50)of the compounds against ETEC were determined using the microdilution method,and a structure-activity relationship analysis was conducted.All the target compounds exhibited antibacterial activity against ETEC,with compound XA2-4 demonstrating the most potent activity(MIC:0.5±0.05 mg/mL,IC50:0.16±0.02 mg/mL).Network pharmacology screening identified recA,metG and pyrG as core targets.Molecular docking studies revealed that the candidate compound XA2-4 exhibited good binding affinity with these core target proteins.qPCR validation results demonstrated that XA2-4 significantly downregulated the expression levels of the recA,metG and pyrG genes,with the pyrG gene being the most sensitive to drug intervention.
年,卷(期):
2026, 89(9)
机标分类号:
R285.5
S476
S852.61
在线出版日期:
2026年10月19日
基金项目:
:黑龙江省博士后启动项目QN2021001:牡丹江师范学院校级项目,